helicobacter pylori kx2 npgec | burkholderia pseudomallei | yersinia enterocolitica p60 bc | pseudomonas aeruginosa | GeneSet Name |
-0.01414 | -0.00050 | -0.11233 | -0.00115 | NUYTTEN_EZH2_TARGETS_DN |
-0.00489 | -0.00532 | -0.08472 | -0.01279 | ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP |
-0.00105 | -0.00064 | -0.19845 | -0.00096 | REACTOME_CELL_CYCLE_MITOTIC |
-0.00219 | -0.00007 | -0.11972 | -0.08688 | BENPORATH_MYC_MAX_TARGETS |
-0.05953 | -0.02431 | -0.17075 | -0.05658 | CORUM_ANTI-HDAC2_COMPLEX |
-0.00868 | -0.05466 | -0.09501 | -0.08092 | NCI_CITRIC_ACID_CYCLE__TCA_CYCLE_ |
-0.00238 | -0.01791 | -0.15253 | -0.02512 | JIANG_HYPOXIA_CANCER |
-0.00389 | -0.12226 | -0.06568 | -0.12361 | REACTOME_CONVERSION_FROM_APC_CDC20_TO_APC_CDH1_IN_LATE_ANAPHASE |
-0.00003 | -0.02029 | -0.07433 | -0.00423 | REACTOME_CELL_CYCLE_CHECKPOINTS |
-0.00119 | -0.01882 | -0.01205 | -0.09607 | NCI_PHOSPHORYLATION_OF_THE_APC_C |
-0.03797 | -0.00036 | -0.06562 | -0.08242 | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN |
-0.02319 | -0.00040 | -0.00157 | -0.04935 | KEGG_OXIDATIVE_PHOSPHORYLATION |
-0.00236 | -0.00001 | -0.00357 | -0.04469 | KEGG_PARKINSONS_DISEASE |
-0.00786 | -0.03491 | -0.11532 | -0.02675 | CORUM_F1F0-ATP_SYNTHASE_EC_3.6.3.14_MITOCHONDRIAL |
-0.00684 | -0.00947 | -0.03830 | -0.02050 | NCI_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS |
-0.00279 | -0.17314 | -0.02372 | -0.06955 | NCI_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS |
-0.04586 | -0.07082 | -0.16036 | -0.01258 | GARY_CD5_TARGETS_DN |
-0.01433 | -0.01053 | -0.03595 | -0.01596 | NCI_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A |
-0.11048 | -0.08712 | -0.04471 | -0.07790 | LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q |
-0.13754 | -0.08755 | -0.01872 | -0.13558 | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS |
-0.00265 | -0.09825 | -0.07435 | -0.07540 | NCI_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE |
-0.02714 | -0.08661 | -0.07605 | -0.13851 | CORUM_ANAPHASE-PROMOTING_COMPLEX |
-0.01571 | -0.05144 | -0.11943 | -0.02813 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING |
-0.00430 | -0.00725 | -0.00010 | -0.02880 | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN |
-0.01265 | -0.00012 | -0.03477 | -0.10608 | ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN |
-0.00281 | -0.01448 | -0.02990 | -0.01134 | REACTOME_INACTIVATION_OF_APC_VIA_DIRECT_INHIBITION_OF_THE_APCOMPLEX |
-0.00331 | -0.02855 | -0.18405 | -0.13662 | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS |
-0.00755 | -0.02537 | -0.03372 | -0.03277 | NCI_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B |
-0.00238 | -0.01195 | -0.02778 | -0.01356 | NCI_INACTIVATION_OF_APC_C_VIA_DIRECT_INHIBITION_OF_THE_APC_C_COMPLEX |
-0.10216 | -0.00204 | -0.01804 | -0.01021 | MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN |
-0.00203 | -0.02193 | -0.03481 | -0.03678 | REACTOME_APCDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B |
-0.04797 | -0.00350 | -0.18701 | -0.03631 | CORUM_SNF2H-COHESIN-NURD_COMPLEX |
-0.00920 | -0.03184 | -0.04171 | -0.14610 | OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP |
-0.00171 | -0.05126 | -0.12019 | -0.02984 | NCI_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING |
-0.00014 | -0.01297 | -0.08096 | -0.01943 | NCI_REGULATION_OF_APC_C_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE |
-0.00139 | -0.01561 | -0.13372 | -0.10992 | REACTOME_CITRIC_ACID_CYCLE |
-0.00137 | -0.03217 | -0.01438 | -0.09563 | REACTOME_PHOSPHORYLATION_OF_THE_APC |
-0.09528 | -0.13480 | -0.14836 | -0.18498 | CORUM_RAD17-RFC_COMPLEX |
-0.15205 | -0.01443 | -0.00507 | -0.03758 | KEGG_NUCLEOTIDE_EXCISION_REPAIR |